Creating a new model to study and treat Cushing's disease
Official title: Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease
Funded at University of Georgia · NIH-11093325 · Data updated 2026-11-12
This study is creating a new lab model of pituitary tumors that cause Cushing's disease, so researchers can better understand the condition and find more effective treatments for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project start | December 25, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $426,428 |
| NIH project number | 5R01DK133325-04 |
| Project ID | NIH-11093325 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Cushing's disease, particularly those who have not responded well to existing treatments.
✕Less likely to help
Patients with Cushing's disease who have already achieved remission or those with other unrelated health conditions may not benefit from this research.
What this research studies
This research focuses on developing a novel organoid model that mimics pituitary adenomas, which are tumors that cause Cushing's disease by producing excess adrenocorticotropic hormone (ACTH). By using this advanced 3D cell culture technique, researchers aim to better understand the disease and test new treatment options that are more effective than current therapies. The goal is to create a preclinical model that accurately reflects the complexity of the tumor tissue, which could lead to improved therapeutic strategies for patients suffering from Cushing's disease.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for patients with Cushing's disease, improving their quality of life and health outcomes.
How similar studies have gone: While the approach of using organoid models is gaining traction, this specific application for Cushing's disease is relatively novel and has not been extensively tested in prior research.
Where this research is happening
-
University of Georgia
Athens, United States Active
Researchers
- Principal investigator: Zavros, Yana — University of Georgia
- Study coordinator: Zavros, Yana
Related research
Other NIH-funded projects on the same topics.
-
Understanding CAG repeat instability in Huntington’s disease
A Huntington’s disease study explores why the CAG repeat in the HTT gene becomes unstable and leads to earlier disease, aiming to uncover factors that influence when and how the disease starts.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.